You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 3, 2024

Ketoprofen - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for ketoprofen and what is the scope of freedom to operate?

Ketoprofen is the generic ingredient in six branded drugs marketed by Actavis Labs Fl Inc, Alkermes Gainesville, Mylan, Wyeth Pharms Inc, Misemer, Rising, Teva, Wyeth Ayerst, Novartis, Bayer, Perrigo, and Wyeth Cons, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for ketoprofen. Five suppliers are listed for this compound.

Drug Prices for ketoprofen

See drug prices for ketoprofen

Drug Sales Revenue Trends for ketoprofen

See drug sales revenues for ketoprofen

Recent Clinical Trials for ketoprofen

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Gustavo Avila-Ortiz DDS, MS, PhDPhase 4
Osteology FoundationPhase 4
University of IowaPhase 4

See all ketoprofen clinical trials

Pharmacology for ketoprofen
Medical Subject Heading (MeSH) Categories for ketoprofen

US Patents and Regulatory Information for ketoprofen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer ACTRON ketoprofen TABLET;ORAL 020499-001 Oct 6, 1995 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Misemer KETOPROFEN ketoprofen CAPSULE;ORAL 074014-001 Jan 29, 1993 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Misemer KETOPROFEN ketoprofen CAPSULE;ORAL 074014-003 Jan 29, 1993 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Pharms Inc ORUVAIL ketoprofen CAPSULE, EXTENDED RELEASE;ORAL 019816-003 Feb 8, 1995 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan KETOPROFEN ketoprofen CAPSULE, EXTENDED RELEASE;ORAL 075679-002 Feb 20, 2002 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ketoprofen

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst ORUDIS ketoprofen CAPSULE;ORAL 018754-001 Jul 31, 1987 ⤷  Sign Up ⤷  Sign Up
Wyeth Ayerst ORUDIS ketoprofen CAPSULE;ORAL 018754-003 Jan 9, 1986 ⤷  Sign Up ⤷  Sign Up
Wyeth Ayerst ORUDIS ketoprofen CAPSULE;ORAL 018754-002 Jan 9, 1986 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.